Regulation of the inflammatory component in chronic dry eye disease by the eye-associated lymphoid tissue (EALT)

Developments in Ophthalmology

Volumn 45, Issue , 2010, Pages 23-39

  Knop, Nadja ^a   Knop, Erich ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; CHRONIC DISEASE; CONJUNCTIVA; DACRYOCYSTITIS; DRY EYE; HUMAN; IMMUNOLOGY; LACRIMAL APPARATUS; LYMPHOID TISSUE; MUCOSAL IMMUNITY; PHYSIOLOGY;

ANIMALS; CHRONIC DISEASE; CONJUNCTIVA; DACRYOCYSTITIS; DRY EYE SYNDROMES; HUMANS; IMMUNITY, MUCOSAL; LACRIMAL APPARATUS; LYMPHOID TISSUE;

EID: 84926112007     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000315017     Document Type: Article

References (87)

1. Knop E, Knop N: A functional unit for ocular surface immune defense formed by the lacrimal gland, conjunctiva and lacrimal drainage system. Adv Exp Med Biol 2002;506:835-844.
2. Knop E, Knop N: New techniques in lacrimal gland research: the magic juice and how to drill for it. Opthalmic Res 2008;40:2-4.
3. Knop E, Knop N: Lacrimal drainage associated lym-phoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci 2001; 42:566-574.
4. Knop E, Knop N: The role of eye-associated lym-phoid tissue in corneal immune protection. J Anat 2005;206:271-285.
5. Knop E, Knop N: Anatomy and immunology of the ocular surface; in Niederkorn J Y, Kaplan HJ (eds): Immune Response and the Eye. Basel, Karger, 2007, pp 36-49.
6. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC: The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-589.
7. Brewitt H, Sistani F: Dry eye disease: the scale of the problem. Surv Ophthalmol 2001;45(suppl 2):S199-S202.
8. Schaumberg DA, Sullivan DA, Dana MR: Epidemiology of dry eye syndrome. Adv Exp Med Biol 2002; 506:989-998.
9. Sullivan DA: Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. Ocul Surf 2004;2:92-123.
10. Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocul Surf 2004;2:124-130.
11. Knop E, Knop N, Brewitt H: Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface: new impulses to understanding dry eye disease (in German). Ophthalmologe 2003; 100:917-928.
12. Knop E, Knop N: Influence of the eye-associated lymphoid tissue (EALT) on inflammatory ocular surface disease. Ocul Surf 2005;3:S180-S186.
13. McDermott AM, Perez V, Huang AJ, Pflugfelder SC, Stern ME, Baudouin C, Beuerman RW, Burns AR, Calder VL, Calonge M, Chodosh J, Coster DJ, Dana R, Hazlett LD, Jones DB, Kim SK, Knop E, Li DQ, Mitchell BM, Niederkorn JY, Pearlman E, Wilhelmus KR, Kurie E: Pathways of corneal and ocular surface inflammation: a perspective from the Cullen symposium. Ocul Surf 2005;3:S131-S138.
14. Argueso P, Gipson IK: Epithelial mucins of the ocular surface: structure, biosynthesis and function. Exp Eye Res 2001;73:281-289.
15. Kraehenbuhl J P, Neutra MR: Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev 1992;72:853-879.
16. Brandtzaeg P, Pabst R: Let's go mucosal: communication on slippery ground. Trends Immunol 2004; 25:570-577.
17. Sack RA, Beaton A, Sathe S, Morris C, Willcox M, Bogart B: Towards a closed eye model of the pre-ocular tear layer. Prog Retin Eye Res 2000;19:649-668.
18. Stahl JL, Cook EB, Barney NP, Graziano FM: Pathophysiology of ocular allergy: the roles of con-junctival mast cells and epithelial cells. Curr Allergy Asthma Rep 2002;2:332-339.
19. Zhan H, Towler HM, Calder VL: The immunomod-ulatory role of human conjunctival epithelial cells. Invest Ophthalmol Vis Sci 2003;44:3906-3910.
20. Sack RA, Conradi L, Krumholz D, Beaton A, Sathe S, Morris C: Membrane array characterization of 80 chemokines, cytokines, and growth factors in open-and closed-eye tears: angiotensin and other defense system constituents. Invest Ophthalmol Vis Sci 2005;46:1228-1238.
21. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M: Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 2003;111:1185-1199.
22. Hazlett LD: Pathogenic mechanisms of P. a e r u g i-nosa keratitis: a review of the role of T cells, Lan-gerhans cells, PMN, and cytokines. DNA Cell Biol 2002;21:383-390.
23. Knop E, Knop N, Claus P: Local production of secretory IgA in the eye-associated lymphoid tissue (EALT) of the normal human ocular surface. Invest Ophthalmol Vis Sci 2008;49:2322-2329.
24. McDermott AM: Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf 2004;2:229-247.
25. Pearlman E, Johnson A, Adhikary G, Sun Y, Chin-nery HR, Fox T, Kester M, McMenamin PG: Tolllike receptors at the ocular surface. Ocul Surf 2008; 6:108-116.
26. von Andrian UH, Mackay CR: T-cell function and migration: two sides of the same coin. N Engl J Med 2000;343:1020-1034.
27. Knop E, Knop N: Lymphocyte homing in the mucosal immune system to the eye-associated lym-phoid tissue (EALT); in Zierhut M, Sullivan DA, Stern ME (eds): Immunology of the Ocular Surface and Tearfilm. Amsterdam, Swets & Zeitlinger, 2004, pp 35-72.
28. Kessing SV: Mucous gland system of the conjunctiva: a quantitative normal anatomical study. Acta Ophthalmol Copenh 1968;(suppl 95):1-133.
29. Osterlind G: An investigation into the presence of lymphatic tissue in the human conjunctiva, and its biological and clinical importance. Acta Ophthalmol Copenh 1944;23(suppl):1-79.
30. Allansmith MR, Greiner J V, Baird RS: Number of inflammatory cells in the normal conjunctiva. Am J Ophthalmol 1978;86:250-259.
31. Franklin RM, Kenyon KR, Tomasi TB Jr: Immuno-histologic studies of human lacrimal gland: localization of immunoglobulins, secretory component and lactoferrin. J Immunol 1973;110:984-992.
32. Wieczorek R, Jakobiec FA, Sacks EH, Knowles DM: The immunoarchitecture of the normal human lac-rimal gland: relevancy for understanding pathologic conditions. Ophthalmology 1988;95:100-109.
33. Sacks EH, Wieczorek R, Jakobiec FA, Knowles DM: Lymphocytic subpopulations in the normal human conjunctiva: a monoclonal antibody study. Ophthalmology 1986;93:1276-1283.
34. Dua HS, Gomes JA, Jindal VK, Appa SN, Schwarting R, Eagle RC Jr, Donoso LA, Laibson PR: Mucosa specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland. Curr Eye Res 1994;13:87-93.
35. Hingorani M, Metz D, Lightman SL: Characterisation of the normal conjunctival leukocyte population. Exp Eye Res 1997;64:905-912.
36. Chandler J W, Gillette TE: Immunologic defense mechanisms of the ocular surface. Ophthalmology 1983;90:585-591.
37. Knop E, Knop N: MALT tissue of the conjunctiva and nasolacrimal system in the rabbit and human. Vis Res 1996;36:S60.
38. Knop E, Knop N: The mucosa associated lymphoid tissue of the human conjunctiva consists of three components: solitary follicles, crypt associated MALT and a lymphoid layer. Invest Ophthalmol Vis Sci 1997;38:S125.
39. Knop N, Knop E: The lacrimal sac in the rabbit and human is associated with MALT. Vis Res 1996;36: S195.
40. Knop N, Knop E: The MALT tissue of the ocular surface is continued inside the lacrimal sac in the rabbit and human. Invest Ophthalmol Vis Sci 1997; 38:S126.
41. Paulsen F P, Paulsen JI, Thale AB, Schaudig U, Tillmann BN: Organized mucosa-associated lym-phoid tissue in human naso-lacrimal ducts. Adv Exp Med Biol 2002;506:873-876.
42. Knop E: Concept of an Eye-Associated Lymphoid Tissue (EALT) as a Functional Unit for Ocular Surface Immune Defence (in German). Hannover, Medical School Hannover, 2001.
43. Knop E, Knop N: Fine structure of high endothelial venules in the human conjunctiva. Ophthalmic Res 1998;30:169.
44. Knop E, Knop N: High endothelial venules are a normal component of lymphoid tissue in the human conjunctiva and lacrimal sac. Invest Ophthalmol Vis Sci 1998;39:S548.
45. Haynes RJ, Tighe PJ, Scott RA, Dua HS: Human conjunctiva contains high endothelial venules that express lymphocyte homing receptors. Exp Eye Res 1999;69:397-403.
46. Knop E, Knop N: Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system (in German). Ophthalmologe 2003; 100:929-942.
47. Knop N, Knop E: Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000;41:1270-1279.
48. Mougneau E, Hugues S, Glaichenhaus N: Antigen presentation by dendritic cells in vivo. J Exp Med 2002;196:1013-1016.
49. Dana MR: Corneal antigen-presenting cells: diversity, plasticity, and disguise: The Cogan Lecture. Invest Ophthalmol Vis Sci 2004;45:722-727.
50. Matzinger P: The danger model: a renewed sense of self. Science 2002;296:301-305.
51. Pflugfelder SC, De Paiva CS, Tong L, Luo L, Stern ME, Li DQ: Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease. Ocul Surf 2005;3:S154-S157.
52. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002;99:351-358.
53. Brandtzaeg P, Baekkevold ES, Farstad IN, Jahnsen FL, Johansen FE, Nilsen EM, Yamanaka T: Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999;20:141-151.
54. Nesburn AB, Bettahi I, Dasgupta G, Chentoufi AA, Zhang X, You S, Morishige N, Wahlert AJ, Brown DJ, Jester J V, Wechsler SL, BenMohamed L: Functional Foxp3+ CD4+CD25(Bright+) 'natural' regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T Cells during ocular herpes infection. J Virol 2007; 81:7647-7661.
55. Siemasko KF, Gao J, Calder VL, Hanna R, Calonge M, Pflugfelder SC, Niederkorn JY, Stern ME: In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci 2008;49:5434-5440.
56. Bettelli E, Oukka M, Kuchroo VK: TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-350.
57. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK: Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000;118:1489-1496.
58. Pflugfelder SC: Tear fluid influence on the ocular surface. Adv Exp Med Biol 1998;438:611-617.
59. Luo L, Li DQ, Corrales RM, Pflugfelder SC: Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005;31: 186-193.
60. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC: Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-4301.
61. Gao J, Morgan G, Tieu D, Schwalb TA, Luo JY, Wheeler LA, Stern ME: ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjogrens syndrome-like MRL/lpr mice. Exp Eye Res 2004;78:823-835.
62. Mircheff AK, Wang Y, Jean MS, Ding C, Trousdale MD, Hamm-Alvarez SF, Schechter JE: Mucosal immunity and self-tolerance in the ocular surface system. Ocul Surf 2005;3:182-192.
63. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC: The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004;78:409-416.
64. Knop E, Knop N: Eye associated lymphoid tissue (EALT) and the ocular surface. Proc 5th Int Symp Ocul Pharmacol Ther, Bologna, Medimond, 2004, pp 91-98.
65. Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J, Siemasko K: Desiccating stress induces T cell-mediated Sjogren's syndromelike lacrimal keratoconjunctivitis. J Immunol 2006; 176:3950-3957.
66. Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, Reis BL, Whitcup SM, Thompson D, Smith JA: Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Invest Ophthalmol Vis Sci 2002;43:2609-2614.
67. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D: Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome kerato-conjunctivitis sicca. Curr Eye Res 1999;19:201-211.
68. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC: A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 1998;438:643-651.
69. Jones DT, Monroy D, Ji Z, Pflugfelder SC: Alterations of ocular surface gene expression in Sjogren's syndrome. Adv Exp Med Biol 1998;438:533-536.
70. Knop E, Knop N, Pleyer U: Clinical Aspects of MALT; in Pleyer U, Mondino B (eds): Uveitis and Immunological Disorders. Berlin, Springer, 2004, pp 67-89.
71. Heiligenhaus A, Koch JM, Kemper D, Kruse FE, Wau-bke TN: Therapy in tear film deficiencies (in German). Klin Monatsbl Augenheilkd 1994;204:162-168.
72. Shimazaki J, Sakata M, Tsubota K: Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113: 1266-1270.
73. Foulks GN, Bron AJ: Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003;1:107-126.
74. Korb DR, Henriquez AS: Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc 1980;51:243-251.
75. Knop N, Knop E: Meibomian glands. I. Anatomy, embryology and histology of the Meibomian glands. Ophthalmologe 2009;106:884-892.
76. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW: Functional aspects of the tear film lipid layer. Exp Eye Res 2004;78:347-360.
77. Knop E, Knop N: Meibomian glands. II. Physiology, characteristics, distribution and function of meibo-mian oil. Ophthalmologe 2009;106:884-892.
78. Brewitt H, Kaercher T, Rüfer F: Dry eye and blepharitis. Klin Monatsbl Augenheilkd 2008;225: R15-R36.
79. Knop E, Knop N, Brewitt H, Pleyer U, Rieck P, Seitz B, Schirra F: Meibomian glands. III. Meibomian gland dysfunction (MGD)-argument for a discrete disease entity and as an important cause of dry eye. Ophthalmologe 2009;106:966-979.
80. Knop E, Knop N: Meibomian glands. IV. Functional interactions in the pathogenesis of meibomian gland Dysfunction (MGD). Ophthalmologe 2009; 106:980-987.
81. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC: Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40:2506-2512.
82. Bron AJ, Yokoi N, Gafney E, Tiffany JM: Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 2009;7:78-92.
83. Sullivan DA, Krenzer KL, Sullivan BD, Tolls DB, Toda I, Dana MR: Does androgen insufficiency cause lacri-mal gland inflammation and aqueous tear deficiency? Invest Ophthalmol Vis Sci 1999;40:1261-1265.
84. Sullivan DA, Sullivan BD, Evans JE, Schirra F, Yama-gami H, Liu M, Richards SM, Suzuki T, Schaumberg DA, Sullivan RM, Dana MR: Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 2002;966:211-222.
85. Brandtzaeg P, Baekkevold ES, Morton HC: From B to A the mucosal way. Nat Immunol 2001;2:1093-1094.
86. Hykin PG, Bron AJ: Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992;11:334-342.
87. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR: The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 2005;46:2766-2771.